Background: Chronic wounds fail to progress through a normal sequence of repair. This study aimed to evaluate the chronic wound patient journey among healthcare professionals (HCPs) and patients in Indian settings.

Methods: A survey questionnaire was framed, including patient burden, initial diagnosis and treatment preference, referral pathway, challenges, and unmet needs of HCPs and patients.

Results: A total of 100 HCPs and 30 patients participated in the survey. The primary challenges faced by the patients include high treatment costs and accessibility to healthcare centres while HCPs reported high treatment cost and lack of awareness as challenges. Affordable treatment options and lack of awareness were cited as prime unmet needs by both HCPs and patients.

Conclusion: The use of adapted products and early initiation of treatment can aid in faster wound healing and can be cost-effective.

Authors:

Arun Bal, Sanjay Vaidya, Rajiv Parakh, Vivekanand, Pavan Belehalli, Madhu Periasamy, Jessy Thomas, Bharat Kotru, Beulah Priyadharshini D R, Venugopal K and Pratik Bhide

Arun Bal is Consultant Diabetic Foot Surgeon, S L Raheja Hospital, Mumbai, India;

Sanjay Vaidya is Consultant Plastic Surgeon, S L Raheja Hospital, Mumbai, India;

Rajiv Parakh is Consultant– Peripheral Vascular and Endovascular Surgery, Medanta Hospital, Gurugram, India;

Vivekanand is Consultant Vascular Surgeon, BMJ Hospital, Bangalore, India;

Pavan Belehalli is Orthopaedic Surgeon, KIER, Bangalore, India;

Madhu Periasamy is Consultant Plastic Surgeon, Ganga Hospital, Coimbatore, India;

Jessy Thomas is Surgeon – Podiatry, Hiranandani Hospital, Mumbai, India;

Bharat Kotru is Podiatrist and Wound Care Specialist, Max Hospital and Amandeep Hospital, Amritsar, India;

Beulah Priyadharshini D R is Medical Affairs Manager – India, Urgo Medical;

Venugopal K is Medical Affairs & Training Specialist – India, Urgo Medical;

Pratik Bhide is Managing Director, India, Urgo Medical

Providencia rettgeri is a Gram-negative bacillus that is most usually seen in urinary tract infections. Skin and soft tissue infections with P rettgeri are rare and there few case reports described in the literature. A 43-year old woman presented to the emergency department with a leg ulcer of 3 months duration. Microbiological results isolated P rettgeri and Pseudomonas aeruginosa. She underwent surgical debridement and split-thickness skin grafting alongside IV antibiotic therapy and dressing care, with complete resolution of the wound 3 months after admission. The differential diagnosis of leg ulcers is wide and must include infection and venous insufficiency. Although venous ulcers are common, typically they are not responsible for rapid evolving ulcers that destroy tissues below the muscular fascia. In this case report, the authors hypothesise that P rettgeri had a major role in the severity of the ulcer in an otherwise healthy woman. A greater understanding of how P rettgeri affects wound pathophysiology is needed in order to distinguish between colonisation versus infection and discriminate bacterial synergy, as well as having better treatment guidelines.

Authors:

Miguel Veríssimo, Diogo Guimarães, Diogo Casal, Sara Carvalho, Miguel Matias, Raquel Barbosa and Joaquim Bexiga

Miguel Veríssimo is Resident. Diogo Guimarães is Resident. Diogo Casal is Attending Physician. Sara Carvalho is Attending Physician. Miguel Matias is Resident. Raquel Barbosa is Resident. Joaquim Bexiga is Attending Physician. All at Plastic Surgery Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.

What makes a good formulary?

The importance of evidencebased practice

Considering cost

Change management

Addressing challenges and

measuring success

BEST PRACTICE STATEMENT: DEVELOPMENT OF A WOUND CARE FORMULARY USING CLINICAL EVIDENCE AND ENSURING EFFECTIVE CHANGE MANAGEMENT

PUBLISHED BY:

Wounds UK

A division of Omniamed Communications, 108 Cannon Street London EC4N 6EU, UK www.wounds-uk.com

This document has been developed by Wounds UK and is supported by an unrestricted educational grant from Urgo Medical.

This publication was coordinated by Wounds UK with the Expert Working Group and Review Panel. The views presented in this document are the work of the authors and do not necessarily

How to cite this document:

Wounds UK (2023) Best Practice Statement: Development of a wound care formulary using clinical evidence and ensuring effective change management. Wounds UK, London. Available to download from: www.woundsuk.com reflect the views of Urgo Medical.

EXPERT WORKING GROUP:

Jacqui Fletcher OBE (Chair), Independent Nurse Consultant

Andrew Sharpe, Advanced Podiatrist, Wound Care, Salford Care Organisation, Salford

Caroline Dowsett, Clinical Nurse Specialist, Tissue Viability Services, East London NHS Foundation Trust

David Wylie, Managing Director, DAWN Health & Care Consultancy UK Ltd; Honorary Fellow, Glasgow Caledonian University, Glasgow

Dawn Douglas, Community Matron, Northumbria Healthcare NHS Foundation Trust

Graham Bowen, Principal Podiatrist, Solent NHS Trust

Hollie Robinson, Tissue Viability Service Lead, South Warwickshire NHS Foundation Trust

Joy Tickle, Tissue Viability Nurse Consultant, Isle of Wight NHS Trust

Kelly Phillips, Skin Integrity Lead Nurse, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

Leanne Atkin, Vascular Nurse Consultant, Mid Yorkshire NHS Trust; Research Fellow, University of Huddersfield

Michelle Goodeve, Senior Diabetes Specialist Podiatrist, Provide Community Interest Company

Nina Murphy, Operational Lead for Tissue Viability, North East London NHS Foundation Trust

Rebecca Elwell, Trustee, British Lymphology Society; Macmillan Lymphoedema ANP and Team Leader, University Hospitals of North Midlands NHS Trust

Sian Fumarola, Head of Clinical Procurement, North Midlands and Black Country NHS Procurement Group

Jane Diggle

Specialist Diabetes Nurse

Practitioner, West Yorkshire

Citation: Diggle J (2023) Updates in the management of cardiovascular disease. Diabetes & Primary Care 25: 145–7